The pharmaceutical industry, a cornerstone of modern healthcare, is also a notable contributor to environmental antibiotic pollution. The industry’s varying effluent management practices result in contaminated pharmaceutical wastewater discharge, harming water sources and ecosystems. Urgent collaborative efforts are required, bringing together policymakers, regulators, manufacturers, researchers, civil society, and communities. The adoption of a One Health approach, recognizing the interconnectedness of human, animal, and environmental health, is essential to curb the spread of AMR.
Antimicrobial resistance (AMR) poses a significant and escalating threat to global health, particularly in low- and middle-income countries (LMICs). This issue, highlighted by Rehab A. Rayan from the Department of Epidemiology at Alexandria University in Egypt, has prompted a call to action published in the journal Biosafety and Health. The repercussions of AMR extend beyond prolonged illnesses, giving rise to heightened antimicrobial use, increased healthcare expenses, and avoidable deaths. If left unchecked, AMR could drive 24 million people into severe poverty by 2030, obstructing progress on Sustainable Development Goals (SDGs).
AMR is not confined to isolated pockets but rather spreads through interconnected ecosystems. Humans, animals, and the environment serve as reservoirs for the dissemination of antimicrobial resistance. A critical contributor to this phenomenon is pharmaceutical wastewater, laden with antibiotics and resistance genes. The inadequate treatment and irresponsible disposal of this wastewater pose a significant environmental risk.
Addressing the environmental impact of AMR necessitates the development of global standards for pharmaceutical effluent antibiotic residues. Additionally, effective treatment methods and improved diagnostics are vital components of a comprehensive strategy to combat AMR. National action plans should be formulated, encompassing a range of strategies to preserve antibiotic efficacy and ensure sustainable production.
A united front from all stakeholders is imperative in the battle against AMR. Collaborative efforts should focus on establishing and implementing global standards, fostering innovation in treatment methods, and enhancing diagnostics. Policymakers must work alongside regulators, manufacturers, researchers, and civil society to create a harmonized approach that transcends geographical and sectoral boundaries.

There’s Only One Green Planet by Tiny Rescue: Climate Collection
Easy Ways to Help the Planet:
Get your favorite articles delivered right to your inbox! Sign up for daily news from OneGreenPlanet.
Help keep One Green Planet free and independent! Together we can ensure our platform remains a hub for empowering ideas committed to fighting for a sustainable, healthy, and compassionate world. Please support us in keeping our mission strong.
Comments: